{"id":"https://openalex.org/W4377942136","doi":"https://doi.org/10.1186/s12885-023-10960-w","title":"Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials","display_name":"Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials","publication_year":2023,"publication_date":"2023-05-24","ids":{"openalex":"https://openalex.org/W4377942136","doi":"https://doi.org/10.1186/s12885-023-10960-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/37226111","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10207853"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-023-10960-w","doi":"https://doi.org/10.1186/s12885-023-10960-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-023-10960-w","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-023-10960-w","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-023-10960-w","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080057262","display_name":"Danxue Huang","orcid":"https://orcid.org/0009-0000-3855-922X","observed_orcids":["https://orcid.org/0009-0000-3855-922X"]},"institutions":[{"id":"https://openalex.org/I4210161255","display_name":"Liaoning Cancer Hospital & Institute","ror":"https://ror.org/05d659s21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161255"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Danxue Huang","raw_affiliation_strings":["Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China. huangdanxue@163.com","Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China. huangdanxue@163.com","institution_ids":["https://openalex.org/I4210161255"]},{"raw_affiliation_string":"Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China","institution_ids":["https://openalex.org/I4210161255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045777835","display_name":"Liyuan Ke","orcid":"https://orcid.org/0009-0005-0398-6885","observed_orcids":["https://orcid.org/0009-0005-0398-6885"]},"institutions":[{"id":"https://openalex.org/I4210161255","display_name":"Liaoning Cancer Hospital & Institute","ror":"https://ror.org/05d659s21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161255"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liyuan Ke","raw_affiliation_strings":["Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China","institution_ids":["https://openalex.org/I4210161255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030203947","display_name":"Hongxia Cui","orcid":"https://orcid.org/0000-0002-0137-2450","observed_orcids":["https://orcid.org/0000-0002-0137-2450"]},"institutions":[{"id":"https://openalex.org/I4210161255","display_name":"Liaoning Cancer Hospital & Institute","ror":"https://ror.org/05d659s21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161255"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongxia Cui","raw_affiliation_strings":["Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China","institution_ids":["https://openalex.org/I4210161255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101636555","display_name":"Li Su","orcid":"https://orcid.org/0000-0002-4556-6863","observed_orcids":["https://orcid.org/0000-0002-4556-6863"]},"institutions":[{"id":"https://openalex.org/I4210161255","display_name":"Liaoning Cancer Hospital & Institute","ror":"https://ror.org/05d659s21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161255"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Su Li","raw_affiliation_strings":["Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China","institution_ids":["https://openalex.org/I4210161255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080057262"],"corresponding_institution_ids":["https://openalex.org/I4210161255"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":0.7634,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.69787045,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"23","issue":"1","first_page":"474","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.968999981880188},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/unresectable-liver-cancer","display_name":"unresectable liver cancer","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hepatitis-b-virus","display_name":"hepatitis B virus","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9629999995231628},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7210000157356262},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9950000047683716},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8799999952316284},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.9070000052452087},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5400000214576721},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7860000133514404},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.7799999713897705},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9105391502380371},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8228462338447571},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7302688360214233},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6907856464385986},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5297732353210449},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.527531623840332},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.5181995034217834},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5039233565330505},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5026319026947021},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4970724880695343},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4955085515975952},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.48746824264526367},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.4859658479690552},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4784286618232727},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46813663840293884},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3367967903614044},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16096413135528564},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.14516791701316833}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12885-023-10960-w","doi":"https://doi.org/10.1186/s12885-023-10960-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-023-10960-w","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-023-10960-w","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10207853","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10207853","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10207853/pdf/12885_2023_Article_10960.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:37226111","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37226111","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Meta-Analysis"},{"id":"pmh:oai:doaj.org/article:1c221f985e4646febace85df0cdc7f26","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1c221f985e4646febace85df0cdc7f26","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12885-023-10960-w","doi":"https://doi.org/10.1186/s12885-023-10960-w","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-023-10960-w","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-023-10960-w","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4377942136.pdf","grobid_xml":"https://content.openalex.org/works/W4377942136.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1873011119","https://openalex.org/W1971837077","https://openalex.org/W1994193851","https://openalex.org/W2000307707","https://openalex.org/W2002213521","https://openalex.org/W2006774237","https://openalex.org/W2015035059","https://openalex.org/W2079586464","https://openalex.org/W2141444851","https://openalex.org/W2142020092","https://openalex.org/W2597795073","https://openalex.org/W2606367731","https://openalex.org/W2769488285","https://openalex.org/W2769788816","https://openalex.org/W2787358630","https://openalex.org/W2801571624","https://openalex.org/W2898314774","https://openalex.org/W2943041940","https://openalex.org/W2955008365","https://openalex.org/W2969802526","https://openalex.org/W2973068330","https://openalex.org/W2983258509","https://openalex.org/W2990602950","https://openalex.org/W3000074215","https://openalex.org/W3000401463","https://openalex.org/W3020440211","https://openalex.org/W3025022288","https://openalex.org/W3080850044","https://openalex.org/W3128646645","https://openalex.org/W3129917327","https://openalex.org/W3138484572","https://openalex.org/W3166753505","https://openalex.org/W3170423016","https://openalex.org/W3186687411","https://openalex.org/W3194501923","https://openalex.org/W3203289704","https://openalex.org/W4200118825","https://openalex.org/W4200386281","https://openalex.org/W4220931808","https://openalex.org/W4242769447","https://openalex.org/W4283812631","https://openalex.org/W4286249733","https://openalex.org/W4292411533","https://openalex.org/W4292549057","https://openalex.org/W4295837456","https://openalex.org/W4297986221","https://openalex.org/W4307046625","https://openalex.org/W4311018430","https://openalex.org/W4322616502"],"related_works":["https://openalex.org/W6958366442","https://openalex.org/W4283755344","https://openalex.org/W4402603883","https://openalex.org/W3035973553","https://openalex.org/W4309361853","https://openalex.org/W4401792596","https://openalex.org/W4323294117","https://openalex.org/W4388492254","https://openalex.org/W4206761933","https://openalex.org/W4223510226"],"abstract_inverted_index":{"BACKGROUND:":[0],"Hepatocellular":[1],"carcinoma":[2],"(HCC)":[3],"is":[4,19],"the":[5,31,43,47,53,268],"third":[6],"leading":[7],"cause":[8],"of":[9,35,46,55,79,122,142,185,216],"cancer-related":[10],"death,":[11],"worldwide.":[12],"The":[13,139,196],"predominant":[14],"causative":[15],"factor":[16],"for":[17,42,83,103,136,211,267,275,288],"HCC":[18,49,213,277],"hepatitis":[20],"B":[21],"virus":[22],"(HBV)":[23],"infection.":[24],"We":[25],"conducted":[26],"a":[27],"meta-analysis":[28],"to":[29,51,68,170,208],"estimate":[30],"efficacy":[32],"and":[33,50,59,87,100,112,134,150,181,190,224,291],"safety":[34],"PD-1/PD-L1":[36,163,201,271],"inhibitors":[37,164,202,272],"combined":[38],"with":[39,183,239,280],"anti-angiogenic":[40,209,285],"therapy":[41,177,204,274],"first-line":[44],"treatment":[45],"unresectable":[48,172,276],"evaluate":[52],"benefits":[54],"different":[56],"geographic":[57],"regions":[58],"etiology":[60],"stratifications.":[61],"METHODS:":[62],"Randomized":[63],"clinical":[64,130,282],"trials":[65,131],"published":[66],"up":[67],"12th":[69],"November":[70],"2022":[71],"were":[72,91,117,132],"searched":[73],"by":[74],"online":[75],"databases.":[76],"Moreover,":[77],"effects":[78],"hazard":[80],"ratio":[81,98],"(HR)":[82],"overall":[84],"survival":[85,89],"(OS)":[86],"progression-free":[88],"(PFS)":[90],"extracted":[92],"from":[93,125],"included":[94],"studies.":[95],"Pooled":[96],"odds":[97],"(OR)":[99],"95%":[101,147,155,221,229],"CI":[102],"objective":[104],"response":[105],"rate":[106,110],"(ORR),":[107],"disease":[108],"control":[109],"(DCR),":[111],"treatment-related":[113],"adverse":[114],"events":[115],"(TRAEs)":[116],"calculated.":[118],"RESULTS:":[119],"A":[120],"total":[121],"3057":[123],"patients":[124,238],"five":[126],"phase":[127],"III":[128],"randomized":[129],"collected":[133],"reviewed":[135],"this":[137],"meta-analysis.":[138],"pooled":[140],"HR":[141,242,251,258],"OS":[143,217],"(HR":[144,152,218,226],"=":[145,153,219,227,243,246,252,255,259,262],"0.71;":[146],"CI:":[148,156,188,193,222],"0.60-0.85)":[149],"PFS":[151,225],"0.64;":[154,220],"0.53-0.77)":[157],"demonstrated":[158],"significantly":[159,206],"better":[160,179,281],"benefit":[161],"in":[162,214,237],"combination":[165,176,203,273],"group":[166],"than":[167,284],"targeted":[168],"monotherapy":[169,210],"treat":[171],"HCC.":[173],"In":[174],"addition,":[175],"showed":[178],"ORR":[180],"DCR,":[182],"ORs":[184],"3.29":[186],"(95%":[187,192],"1.92-5.62)":[189],"1.88":[191],"1.35-2.61),":[194],"respectively.":[195],"subgroup":[197],"analysis":[198],"indicated":[199],"that":[200,270],"was":[205,233,278],"superior":[207],"HBV-related":[212],"terms":[215],"0.55-0.74)":[223],"0.53;":[228],"CI:0.47-0.59),":[230],"while":[231],"there":[232],"no":[234],"significant":[235],"difference":[236],"HCV":[240],"(OS,":[241,250],"0.81,":[244],"p":[245,254,261],"0.1)":[247],"or":[248],"non-viral":[249],"0.91,":[253],"0.37;":[256],"PFS,":[257],"0.77,":[260],"0.05).":[263],"CONCLUSIONS:":[264],"Meta-analysis":[265],"revealed":[266],"first-time":[269],"associated":[279],"outcomes":[283],"monotherapy,":[286],"especially":[287],"HBV":[289],"infection":[290],"Asian":[292],"population.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-05-25T00:00:00"}